1. Home
  2. FIEE vs NMTC Comparison

FIEE vs NMTC Comparison

Compare FIEE & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FiEE Inc

FIEE

FiEE Inc

N/A

Current Price

$6.90

Market Cap

45.6M

Sector

Utilities

ML Signal

N/A

Logo NeuroOne Medical Technologies Corporation

NMTC

NeuroOne Medical Technologies Corporation

HOLD

Current Price

$4.55

Market Cap

39.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FIEE
NMTC
Founded
1977
2009
Country
Hong Kong
United States
Employees
43
N/A
Industry
Telecommunications Equipment
Medical/Dental Instruments
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
45.6M
39.5M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
FIEE
NMTC
Price
$6.90
$4.55
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$11.90
AVG Volume (30 Days)
9.2K
111.2K
Earning Date
05-14-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
80.43
EPS
N/A
N/A
Revenue
N/A
$9,097,692.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$31.90
P/E Ratio
N/A
N/A
Revenue Growth
N/A
163.47
52 Week Low
$1.50
$0.55
52 Week High
$7.95
$5.40

Technical Indicators

Market Signals
Indicator
FIEE
NMTC
Relative Strength Index (RSI) 48.98 65.13
Support Level $6.60 $0.69
Resistance Level $7.66 $5.40
Average True Range (ATR) 0.55 0.28
MACD -0.05 -0.12
Stochastic Oscillator 62.81 24.60

Price Performance

Historical Comparison
FIEE
NMTC

About FIEE FiEE Inc

FiEE Inc, formerly Minim Inc is a digital service provider focused on integrating artificial intelligence and data analytics into content creation and brand management. The company offers a range of services designed to support creators, artists, and businesses in developing, managing, and optimizing their digital presence across various platforms, including customized graphic and posts, short videos, and editorial calendars aligned with brand goals.

About NMTC NeuroOne Medical Technologies Corporation

NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.

Share on Social Networks: